These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 27081758)

  • 21. [Treatment of murine Lewis lung cancer with recombinant interleukin-12].
    Yin XL; Duan H; Peng ZP; Sun SL; Li SL
    Ai Zheng; 2006 Sep; 25(9):1087-91. PubMed ID: 16965647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble biodegradable polymer-based cytokine gene delivery for cancer treatment.
    Maheshwari A; Mahato RI; McGregor J; Han So; Samlowski WE; Park JS; Kim SW
    Mol Ther; 2000 Aug; 2(2):121-30. PubMed ID: 10947939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment with a fusion protein of the extracellular domains of NKG2D to IL-15 retards colon cancer growth in mice.
    Xia Y; Chen B; Shao X; Xiao W; Qian L; Ding Y; Ji M; Gong W
    J Immunother; 2014 Jun; 37(5):257-66. PubMed ID: 24810637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel kidney cancer immunotherapy based on the granulocyte-macrophage colony-stimulating factor and carbonic anhydrase IX fusion gene.
    Hernández JM; Bui MH; Han KR; Mukouyama H; Freitas DG; Nguyen D; Caliliw R; Shintaku PI; Paik SH; Tso CL; Figlin RA; Belldegrun AS
    Clin Cancer Res; 2003 May; 9(5):1906-16. PubMed ID: 12738749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunotherapy by gene transfer with plasmids encoding IL-12/IL-18 is superior to IL-23/IL-18 gene transfer in a rat osteosarcoma model.
    Liebau C; Roesel C; Schmidt S; Karreman C; Prisack JB; Bojar H; Merk H; Wolfram N; Baltzer AW
    Anticancer Res; 2004; 24(5A):2861-7. PubMed ID: 15517889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells.
    Oshimi Y; Oda S; Honda Y; Nagata S; Miyazaki S
    J Immunol; 1996 Oct; 157(7):2909-15. PubMed ID: 8816396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of antitumor activity of a single-chain interleukin-12 IgG3 antibody fusion protein (mscIL-12.her2.IgG3).
    Peng LS; Penichet ML; Dela Cruz JS; Sampogna SL; Morrison SL
    J Interferon Cytokine Res; 2001 Sep; 21(9):709-20. PubMed ID: 11576465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene therapy with interleukin-10 receptor and interleukin-12 induces a protective interferon-γ-dependent response against B16F10-Nex2 melanoma.
    Marchi LH; Paschoalin T; Travassos LR; Rodrigues EG
    Cancer Gene Ther; 2011 Feb; 18(2):110-22. PubMed ID: 20885448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Superiority of interleukin-12-transduced murine lung cancer cells to GM-CSF or B7-1 (CD80) transfectants for therapeutic antitumor immunity in syngeneic immunocompetent mice.
    Sumimoto H; Tani K; Nakazaki Y; Tanabe T; Hibino H; Wu MS; Izawa K; Hamada H; Asano S
    Cancer Gene Ther; 1998; 5(1):29-37. PubMed ID: 9476964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A single-chain IL-12 IgG3 antibody fusion protein retains antibody specificity and IL-12 bioactivity and demonstrates antitumor activity.
    Peng LS; Penichet ML; Morrison SL
    J Immunol; 1999 Jul; 163(1):250-8. PubMed ID: 10384123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The human ortholog of granulocyte macrophage colony-stimulating factor and interleukin-2 fusion protein induces potent ex vivo natural killer cell activation and maturation.
    Penafuerte C; Bautista-Lopez N; Boulassel MR; Routy JP; Galipeau J
    Cancer Res; 2009 Dec; 69(23):9020-8. PubMed ID: 19920194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Construction of a double recombinant adenovirus vector expressing a heterodimeric cytokine: in vitro and in vivo production of biologically active interleukin-12.
    Bramson J; Hitt M; Gallichan WS; Rosenthal KL; Gauldie J; Graham FL
    Hum Gene Ther; 1996 Feb; 7(3):333-42. PubMed ID: 8835220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activated natural killer cell-mediated immunity is required for the inhibition of tumor metastasis by dendritic cell vaccination.
    Kim A; Noh YW; Kim KD; Jang YS; Choe YK; Lim JS
    Exp Mol Med; 2004 Oct; 36(5):428-43. PubMed ID: 15557815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunization and immunotherapy for cancers involving infection by a human papillomavirus in a mouse model.
    Li J; Sun Y; Garen A
    Proc Natl Acad Sci U S A; 2002 Dec; 99(25):16232-6. PubMed ID: 12446839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune selection and emergence of aggressive tumor variants as negative consequences of Fas-mediated cytotoxicity and altered IFN-gamma-regulated gene expression.
    Liu K; Caldwell SA; Abrams SI
    Cancer Res; 2005 May; 65(10):4376-88. PubMed ID: 15899830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenovirus-mediated expression of interleukin-12 induces natural killer cell activity and complements adenovirus-directed gp75 treatment of melanoma lung metastases.
    Hirschowitz EA; Crystal RG
    Am J Respir Cell Mol Biol; 1999 May; 20(5):935-41. PubMed ID: 10226063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytokine gene therapy using adenovirally transduced, tumor-seeking activated natural killer cells.
    Goding SR; Yang Q; Knudsen KB; Potter DM; Basse PH
    Hum Gene Ther; 2007 Aug; 18(8):701-11. PubMed ID: 17678438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycolipid-anchored IL-12 expressed on tumor cell surface induces antitumor immune response.
    Nagarajan S; Selvaraj P
    Cancer Res; 2002 May; 62(10):2869-74. PubMed ID: 12019166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer.
    Smyth MJ; Swann J; Kelly JM; Cretney E; Yokoyama WM; Diefenbach A; Sayers TJ; Hayakawa Y
    J Exp Med; 2004 Nov; 200(10):1325-35. PubMed ID: 15545356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
    Mizutani Y; Yoshida O; Bonavida B
    J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.